







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Hong et al. 270 (12): 6602</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Biacore%20banner&url=http://www.biacore.com/lifescience/applications/proteomics/proteomics.lasso%3Ftrackid=23&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1050585037.gif" ALT="Biacore"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol270/issue12/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F270%2F12%2F6602">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 





 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/270/12/6602">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/270/12/6602">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;270/12/6602">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/270/12/6602&title=Directed+Mutagenesis+of+Deoxyguanosine+Site+at+Arginine+79+Up-regulates+Turnover+on+Deoxyadenosine+Kinase+Subunit+of+Heterodimeric+Enzyme+from+Lactobacillus+acidophilus+R26">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;270/12/6602&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=7896799&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=7896799&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Hong+YS&link_type=AUTHORSEARCH">Hong, Y. S.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Ives+DH&link_type=AUTHORSEARCH">Ives, D. H.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;270/12/6602&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F270%2F12%2F6602"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;270/12/6602">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<P>
<a name = "top"><!-- comment for mosaic --></a>
<P>

<!-- COPYRIGHT -->
    <H5>
    Volume 270, 
    Number 12, 
    Issue of March 24, 1995 pp. 6602-6606<br>
    &#169;1995 by The American Society for Biochemistry and Molecular Biology, Inc.
    <HR>
    </H5> 
<!-- /COPYRIGHT -->

 




<ATL>

<strong>
<font size=+3>Directed 
Mutagenesis of Deoxyguanosine Site at Arginine 79  Up-regulates 
Turnover on Deoxyadenosine Kinase Subunit of Heterodimeric Enzyme from <i>Lactobacillus acidophilus</i>  R26   <a name="RFN20"><a href="#FN20">(*)</a></a></font></strong>

</ATL>
<P><P ALIGN=RIGHT><font size=-1>(Received for publication, November 9, 1994; and in revised form, January 23, 1995)</font></P><NOBR>
<AU>
<STRONG>

Young Soo


Hong <a name="RFN50"><a href="#FN50">(&#167;)</a></a>,&nbsp;<WBR>

</STRONG>,&nbsp;<WBR>
</AU>
<AU>
<STRONG>

Grace T.


Ma <a name="RFN53"><a href="#FN53">(&#182;)</a></a>,&nbsp;<WBR>

</STRONG>,&nbsp;<WBR>
</AU>
<AU>
<STRONG>

David 
H.


Ives <a name="RFN52"><a href="#FN52">(**)</a></a>

</STRONG>
</AU>
</NOBR><P>From the&nbsp;<AFF>Department of Biochemistry and the Ohio State 
Biochemistry Program, The Ohio State University, Columbus, Ohio 
43210-1292</AFF><SBJ> <!--PROTEIN CHEMISTRY AND STRUCTURE-->
</SBJ><!--############################## ARTICLE NAV ###################################-->
<DL>

	<DD><A HREF="#abs"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">ABSTRACT</A>
	<DD><A HREF="#int"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">INTRODUCTION</A>

		    <DD><A HREF="#SEC1"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">EXPERIMENTAL PROCEDURES</A>

		    <DD><A HREF="#SEC2"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">RESULTS</A>

		    <DD><A HREF="#SEC3"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">DISCUSSION</A>

	<DD><A HREF="#foo"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">FOOTNOTES</A>
	<DD><A HREF="#ref"><IMG border=0 vspace=1 hspace=5 align=top SRC="/icons/down.GIF">REFERENCES</A>
</DL>
<HR>
<ABS>
<P>
<P align=center>
<a name = "abs"><!-- comment for mosaic --></a>
ABSTRACT <A HREF="#top"><IMG border=0 hspace=3 align=top SRC="/icons/back.GIF"></A>
</P>
<P>Examination of conserved motifs on the cloned subunits of the 
deoxyguanosine kinase/deoxyadenosine kinase (dGK/dAK) of <i>Lactobacillus acidophilus</i>  R-26 has begun with the Asp-Arg-Ser 
(DRS) motif. Replacement of Asp-78 of both subunits with Glu, Ala, or 
Asn reduced dGK and dAK activities to less than 0.2%, whereas 
replacement of Arg-79 with Lys, either on both subunits in tandem 
(R79K), or on the dGK subunit only (R79K:dGK), yielded active but 
kinetically modified enzymes. These were partially purified, and their 
kinetic and regulatory properties were analyzed. For dAK activity, the <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  of the R79K:dGK enzyme was increased 28-fold, 
with no change in the limiting <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  for 
dAdo, but with a slightly reduced <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  for 
MgATP. The <i>V/K</i>  efficiency ratio of dAK was also increased 
29-fold, but that of dGK was decreased to 5-10%  due to a 10-fold 
increase in <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  for dGuo and a reduced <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">. Therefore, the R79K substitution seems to 
have a greater effect on dGuo binding than on that of dAdo, but dGK 
modification appears to produce a stimulatory conformational effect on 
the opposite subunit, resembling the known unidirectional activation of 
dAK by either dGuo or dGTP.<P>
</ABS>
<P><HR>
<P align=center>
<a name = "int"><!-- comment for mosaic --></a>
INTRODUCTION <A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
</P>
<TXT>
<P>The four deoxynucleoside kinases of <i>Lactobacillus 
acidophilus</i>  R26 exhibit a level of specificity for their 
respective deoxynucleoside substrates previously unknown among this 
class of enzymes. Although the lactobacilli contain a thymidine kinase 
(TK), <a name="RFN1"><a href="#FN1">(<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_1.gif" ALT="^1">)</a></a>an activity common to nearly all prokaryotes and 
eukaryotes, and which resembles the <i>Escherichia coli</i>  enzyme in 
its regulation, <a name="RFN2"><a href="#FN2">(<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_2.gif" ALT="^2">)</a></a>the other three activities are apparently 
unique in terms of their nucleoside specificities, structural 
organization, and regulation. In contrast with human and other 
mammalian deoxycytidine kinases(<a href = "#B1">1</a>, <a href = "#B2">2</a>, <a href = "#B3">3</a>) , 
which actually phosphorylate dAdo and dGuo, as well as dCyd, at a 
common site, these three activities are found in lactobacilli as two 
heterodimers, dGK/dAK (deoxyguanosine kinase/deoxyadenosine kinase) or 
dCK/dAK (deoxycytidine kinase/deoxyadenosine kinase), and separate 
catalytic functions have recently been assigned to each 
subunit(<a href = "#B4">4</a>) .<P>Each subunit's activity is selectively 
controlled by feed-back inhibition from its respective dNTP end 
product, which (mounting evidence strongly suggests) binds to both the 
nucleoside and ATP sites as a bisubstrate 
inhibitor(<a href = "#B4">4</a>, <a href = "#B5">5</a>) . The other remarkable regulatory 
aspect of these enzyme is the unidirectional activation of dAK, which 
in its unactivated state has only about one-fifth the activity of its 
associated dCK or dGK. However, when dCyd or dGuo, or their 
triphosphate homologs, occupy the respective dCK or dGK subunits, the 
turnover on dAK is increased up to 6-fold. (Curiously, dAdo or dATP 
exert very little stimulatory effect on dCK or dGK, in the opposite 
direction.) This effect is purely a turnover phenomenon; the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  values for dAdo are unchanged by dCyd 
or dGuo(<a href = "#B6">6</a>, <a href = "#B7">7</a>) . Recent evidence suggests that this 
heterotropic activation of dAK is due to conformational changes, 
analogous to the classical taut-to-relaxed inter-conversion, induced 
upon the respective binding of dCyd or dGuo (or their triphosphates) to 
the dCK or dGK active site (<a href = "#B4">4</a>, <a href = "#B8">8</a>) . Under these 
circumstances, the dAK of either dimer becomes more susceptible to 
limited protolysis, presumably by toggling into an open or relaxed 
state, whereas selective proteolytic inactivation of dGK abolished this 
effect(<a href = "#B4">4</a>) . In a related experiment, photoaffinity labeling of 
the dGK active site with 8-azidoadenine permanently locks dAK into an 
activated configuration, again revealing conformational communication 
between the two subunits of the heterodimer(<a href = "#B8">8</a>) .<P>It is of 
great interest to identify the structural basis for these unusual 
regulatory phenomena as well as the sequences contributing to the 
enzymes'  active sites. Scanning for homology with structural 
elements shown to be related to function in other kinases reveals that 
dGK/dAK contains the glycine- and arginine-rich motifs associated with 
the ATP- or GTP-binding sites of many nucleotide-binding proteins (<a href = "#B9">9</a>, <a href = "#B10">10</a>) and which are also highly conserved in the 
adenylate kinases (<a href = "#B11">11</a>) and herpesviral thymidine kinases (HSV 
sites 1 and 5)(<a href = "#B12">12</a>, <a href = "#B13">13</a>) . Another small conserved 
motif, -DRH- (HSV-TK site 3), found between the G-loops and the 
arginine-rich regions of herpesviral thymidine kinases(<a href = "#B12">12</a>) , 
may be analogous to the similarly located DRS motif of dGK/dAK. 
Mutations 4-12 residues further on the HSV-1 TK map (around 
HSV-TK site 4) produced increased <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  values for thymidine, leading Darby <i>et al.</i>(<a href = "#B14">14</a>) to suggest the region may be part of a 
thymidine-binding site. Random oligonucleotide mutagenesis leading to 
the replacement of a number of residues in the intervening region 
between sites 3 and 4 has also produced mutants with both increased and 
decreased <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap485.gif">  and <i>k</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap499.gif">  values for thymidine(<a href = "#B15">15</a>) , whereas a double amino acid 
substitution within this region of varicella-zoster TK (which is 
partially conserved relative to HSV TKs) resulted in reduced thymidine 
and thymidylate kinase activities and larger dissociation constants for 
these and analogous substrates(<a href = "#B16">16</a>) . Significantly, random 
mutagenesis of HSV-1 TK produced no active enzymes with modifications 
within the DRH motif, an indication of its possible importance, and 
site-directed mutagenesis of the corresponding Asp-162 completely 
inactivated the enzyme(<a href = "#B17">17</a>) , making it difficult to say whether 
the mutation affected substrate binding or turnover, or if it produced 
global disruption of structure. But, the essential character of Asp-162 
and its proximity to site 4 would make it seem likely that sites 3 and 
4 are both part of a larger nucleoside-binding or recognition domain 
for HSV-TKs.<P>The homology between the DRS motif of dGK/dAK and the 
DRH of HSV-TKs, although very limited in size, suggested the possible 
importance of these residues in some aspect of nucleoside binding 
and/or catalysis in <i>Lactobacillus</i>  dGK/dAK. Furthermore, since 
the regulatory events described appear to be mediated through 
deoxynucleoside sites, it seemed more desirable to probe potential 
deoxynucleoside sites initially, rather than the recognizable 
ATP-binding elements.<P><HR>
<P align=center>
<a name = "SEC1"><!-- comment for mosaic --></a>EXPERIMENTAL PROCEDURES<A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
</P>
<P><P>
<H4>Materials</H4>2`-Deoxyadenosine and 
2`-deoxyguanosine were purchased from Sigma; 
2`-[2,8-<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_3.gif" ALT="^3">H]deoxyadenosine and 
2`-[8-<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_3.gif" ALT="^3">H]deoxyguanosine were from Moravek 
Biochemicals, Inc. Deoxyadenosine 
5`-[<IMG BORDER=0 ALIGN=BOTTOM SRC="/icons/symbolgifs/chars/alpha.gif" ALT="alpha">-<IMG BORDER=0 ALIGN=TOP SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap507.gif">S]thiotriphosphate was provided by 
Amersham Corp. Bradford reagent and reagents for polyacrylamide gel 
electrophoresis were obtained from Bio-Rad. <i>Escherichia coli</i>  XL1-Blue was from Stratagene. The Sequenase version 2 kit was 
purchased from U. S. Biochemical Corp., and all other materials, 
including protocols, cell lines, and enzymes for the site-directed 
mutagenesis, were from a Muta-Gene<IMG BORDER=0 ALIGN=TOP SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap509.gif">  phagemid <i>in 
vitro</i>  mutagenesis version 2 kit, which was purchased from Bio-Rad. 
Electroporation was done in a Gene Pulser from Bio-Rad, using 0.4-cm 
cuvettes.<P><P>
<H4>Enzyme Assays</H4>Deoxynucleoside kinase activities 
were assayed using DE-81 ion exchange paper by the method of Ives (<a href = "#B18">18</a>) with minor modifications as follows. In the standard 
assay, the final concentration of each reagent in the reaction mixture 
(in a 1.5-ml Eppendorf tube) was: ATP, 10 mM; 
MgCl<IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/smallnumbers/tiny_2.gif" ALT="(2)">, 12 mM; Tris-HCl, pH 8.0, 0.1 M; 
[<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_3.gif" ALT="^3">H]dAdo (for dAK), [<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_3.gif" ALT="^3">H]dGuo 
(for dGK), 0.2 mM  (0.5 &#181;Ci/assay), respectively. The 
reactions were started by adding 20 &#181;l of enzyme diluted in 15 
mM  potassium phosphate buffer, pH 8.0, containing 20%  (v/v) 
glycerol to the warmed reaction mixture tube (final volume, 80 &#181;l). 
After 30 min of incubation at 20 &#176;C, 0.2 ml of 0.1 M  formic acid was added to stop the reaction. Aliquots (20 &#181;l) 
of the mixture were spotted on Whatman DE-81 anion exchange papers for 
the measurement of radioactivity(<a href = "#B18">18</a>) . The protein 
concentration of enzyme solutions was determined by the method of 
Bradford(<a href = "#B19">19</a>) . Specific enzyme activity is defined as the 
nanomoles of product per min per mg of protein. SDS-polyacrylamide gel 
electrophoresis was as described by Laemmli (<a href = "#B20">20</a>) .<P><P>
<H4>Expression of Mutant Enzymes</H4><i>E. coli</i>  XL1-Blue cells containing mutants of the recombinant pBlueScript 
KS(+) clone GTM-K48 were cultured in LB liquid medium, containing 
100 &#181;g/ml ampicillin, for expression of enzyme. Since the cloned 
genes are activated by an endogenous promotor, it was not necessary to 
add isopropyl-1-thio-<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/chars/beta.gif" ALT="beta">-D-galactopyranoside for the 
stimulation of protein expression. The cell pellets were washed in 
ice-cold cell suspension buffer (0.1 M  Tris-HCl, pH 8.0, 25 
mM  EDTA, 20%  glycerol) and used immediately or stored at 
&#45;20 &#176;C for later use. The washed cell pellets were suspended 
in cell suspension buffer, broken by ultrasonication, and centrifuged 
at 13,500 <IMG BORDER=0 ALIGN=BOTTOM SRC="/icons/symbolgifs/hand/mult.GIF" ALT="times">  <i>g</i>  for 1 h at 4 &#176;C. Fraction IV 
enzyme(<a href = "#B21">21</a>) , prepared with only minor modifications yielded 
reproducible linear kinetics.<P><P>
<H4>Site-directed Mutagenesis</H4>The materials and 
protocols of the Muta-Gene phagemid <i>in vitro</i>  site-directed 
mutagenesis kit (version 2) from Bio-Rad was used. Mutagenic 
oligodeoxynucleotides synthesized in the Biochemical Instrument Center 
of The Ohio State University were unblocked at 58 &#176;C for 24 h, 
dried completely under N<IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/smallnumbers/tiny_2.gif" ALT="(2)">  gas, and purified with a Qiagen 
column (tip-20) by the manufacturer's protocol. Pure oligomers 
were dried in air, dissolved in 1 ml of 10 mM  Tris buffer, pH 
8.0, and stored at &#45;20 &#176;C until use. The quality of each 
oligomer was checked by 6%  polyacrylamide gel electrophoresis. The 5` 
end of each mutagenic oligomer was phosphorylated with polynucleotide 
kinase to improve the frequencies of mutagenesis.<P>After the 
polymerization/ligation reaction was continued for 90 min at 37 &#176;C, 
the reaction was stopped by adding Tris-EDTA buffer. Closed-circular 
heteroduplex recombinant pBlueScript KS(+) was extracted from 
agarose electrophoresis gel and used in the transformation of <i>E. 
coli</i>  XL1-Blue by electroporation in a Gene Pulser (Bio-Rad), 
according to the manufacturer's protocol. Transformants were 
grown on LB plates containing ampicillin, and each instance of 
mutagenesis was confirmed by DNA sequencing, using the 
dideoxynucleotide termination method(<a href = "#B22">22</a>) .<P><P>
<H4>Steady State Kinetics</H4>Limiting <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values for deoxynucleoside substrates and MgATP were determined 
by steady state kinetics, varying both nucleoside and ATP 
concentrations. Slope and intercept replots yielded the limiting <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  and <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  values(<a href = "#B23">23</a>) . When ATP concentrations were varied, the 
concentrations of Mg<IMG BORDER=0 ALIGN=TOP SRC="/content/vol270/issue12/fulltext/6602/_6494_tex2html_wrap559.gif">  in the reaction mixtures were 
kept at 120%  of the corresponding ATP concentrations. Dissociation 
constants for the dNTP end product inhibitors were estimated by means 
of Dixon plots that were constructed by replotting reciprocal 
velocities, measured at several substrate concentrations in the 
presence of several concentrations of inhibitor, <i>versus</i>  inhibitor concentration.<P><HR>
<P align=center>
<a name = "SEC2"><!-- comment for mosaic --></a>RESULTS<A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
</P>
<P><P>
<H4>Site-directed Mutagenesis and Preliminary 
Assays</H4>The -DRS- motif or its conservatively substituted analog 
has been implicated as part of the deoxynucleoside site in the HSV TKs. 
Its presence in <i>Lactobacillus</i>  dGK/dAK and its location at the 
N-terminal boundary of a consensus sequence (D/E-R-S-I/V-<i>X</i>-D) 
shared with mammalian deoxycytidine kinases (<a href = "#B24">24</a>, <a href = "#B25">25</a>, <a href = "#B26">26</a>) makes it an attractive initial 
target in the search for the deoxynucleoside active site. We began by 
examining the functional significance of the first two charged 
residues, Asp-78 and Arg-79, on both the dAK and dGK peptides, by means 
of site-directed mutagenesis using the Kunkel (<a href = "#B27">27</a>) method. 
Eight different mutagenic oligomers were synthesized and are shown in <a href = "#T1">Table&nbsp;1</a>. Aspartate 78 of both subunits was replaced with 
glutamate, a supposedly conservative replacement except for the longer 
side chain, with asparagine to eliminate the negative charge and with 
alanine to minimize the volume occupied by the side chain. Since the 
target amino acids may be located in the inner pocket, bulky 
substituents more likely to cause global disruption of the tertiary 
structure were avoided. At the Arg-79 residue substitution with lysine 
only was performed, providing a single positively charged center with a 
smaller side chain. However, two types of mutants were constructed; one 
bears the R79K mutation on both the dAK and dGK subunits, while the 
other has the R79K mutation on the dGK subunit only (R79K:dGK). As it 
is not yet clear whether the dAK subunit is processed in <i>E. coli</i>  host like the wild-type <i>Lactobacillus</i>  enzyme(<a href = "#B24">24</a>) , the product of the unmutated parental gene 
will be referred to as UMCE (<i>u</i>n<i>m</i>odified <i>c</i>loned <i>e</i>nzyme) in this report.<P><!-- TABLE 1 -->
<HR>
<P align=center>
<a name = "T1"><!-- comment for mosaic --></a>
<a HREF="/content/vol270/issue12/images/large/BC1257801001.jpeg">
<img SRC="/content/vol270/issue12/images/medium/BC1257801001.gif"></a>
</P>
<!-- /TABLE 1 -->
<HR>
<P>Both UMCE and 
mutant <i>Lactobacillus</i>  enzymes were expressed in <i>E. coli</i>  at levels amounting to at least 3%  of the total soluble protein in 
crude cell extracts, judging from the intensities of the 27-kDa bands 
resolved by 12%  SDS-polyacrylamide gel electrophoresis (<a href = "#F1">Fig.&nbsp;1</a>). 
The quantities of dAK/dGK peptides expressed by UMCE and mutants 
apparently are identical, and they remain unchanged after 16 h of 
incubation with good aeration at 37 &#176;C, which suggests that there 
is no specific or selective degradation of the expressed foreign 
proteins by <i>E. coli</i>  proteases. The sizes of all of the 
expressed dAK and dGK peptides appear to be identical at about 27 kDa, 
in close agreement with the wild-type <i>L. acidophilus</i>  R26 
dAK/dGK peptides(<a href = "#B4">4</a>) . Crude extracts of all mutants were 
screened for activity by the standard assay. After partial purification 
of the expressed cloned enzyme activities, the relative quantities and 
molecular sizes were unchanged.<P><!--################################# FIGURE 1 #################################-->
<!-- FIG -->
<P>
<a name = "F1"><!-- comment for mosaic --></a>


<a href="/cgi/content/full/270/12/6602/f1">
<img align=left vspace=5 hspace=10 SRC="/content/vol270/issue12/images/small/bc7801001.gif"></a>
<HR>


<P>
<strong>Figure 1:</strong>
<!-- CAP -->SDS-polyacrylamide 
gel electrophoresis profiles of expressed UMCE and mutant enzymes in 
crude extracts. <i>Lanes 1</i>  and <i>9</i>, molecular mass markers 
(Bio-Rad low range); <i>lane 2</i>, pBlueScript transformed cell 
control; <i>lane 3</i>, UMCE; <i>lane 4</i>, D78A; <i>lane 5</i>, 
D78E; <i>lane 6</i>, D68N; <i>lane 7</i>, R79K; <i>lane 8</i>, 
R79K:dGK. Expressed protein is indicated by the <i>arrow</i>.<P><!-- /CAP -->
<BR clear=left>
<HR>
<!-- /FIG -->
<!--################################# FIGURE 1 #################################-->
<P>All three types of Asp-78 mutations 
(D78A, D78E, and D78N, involving both subunits) virtually eliminated 
both dAK and dGK activities, being less than 0.2%  of the activities 
found in comparable UMCE fractions. As the activities of these mutants 
were deemed to be too low for reliable kinetics, further analysis was 
not attempted. While it is quite likely that Asp-78 is directly 
essential for the activities of each subunits, indirect effects such as 
disruption of folding cannot yet be ruled out as an explanation for the 
loss of activities.<P>Charge-conservative mutations at Arg-79, on the 
other hand, had a much more remarkable effect. While preliminary assays 
(not shown) revealed a reduction in the dGK activities of both the R79K 
and R79K:dGK mutants, the dAK activities were <i>increased</i>  dramatically, whether or not the dAK subunit was altered. However, 
there was no apparent increase in the amount of peptide expressed. 
Preliminary enzyme activation and inhibition studies were carried out 
to determine whether these regulatory mechanisms might have been 
altered by R79K mutations. While both mutant enzymes remain susceptible 
to inhibition by end products dGTP or dATP, activation of dAK by dGuo 
is nearly eliminated in the case of the R79K:dGK mutant, while for the 
tandemly mutated R79K, there was even a 30%  inhibition of the dAK 
activity upon addition of dGuo. In the opposite direction, dAdo 
produces, at most, a 10%  stimulation of UMCE dGK, and this small 
stimulation is replaced by a comparable inhibition of the R79K:dGK 
mutant.<P><i>Effects of Arg-79 Mutations on Steady State 
Kinetics</i>-<i></i>Because mutations at or near the active site of an 
enzyme may alter its <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values, or even its kinetic 
mechanism, it is necessary to compare limiting <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  and <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  values (<i>i.e.</i>  extrapolating 
to saturation by both substrates rather than the apparent values 
obtained by varying only one substrate) lest variable second-substrate 
saturation produces apparent differences in reaction velocities. 
Therefore, these parameters were determined for UMCE and each of the 
Arg-79 mutants by steady-state kinetics in which both deoxynucleoside 
and MgATP concentrations were varied (<a href = "#T2">Table&nbsp;2</a>). The limiting <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for dAdo was increased severalfold in the tandem 
mutant (7.5 &#181;M  in R79K) but was unchanged by the dGK-only 
mutation. A greater effect is seen upon the binding of dGuo, with the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for dGuo increasing about an order of magnitude 
on both the single and tandem mutants.<P><!-- TABLE 2 -->
<HR>
<P align=center>
<a name = "T2"><!-- comment for mosaic --></a>
<a HREF="/content/vol270/issue12/images/large/BC1257801002.jpeg">
<img SRC="/content/vol270/issue12/images/medium/BC1257801002.gif"></a>
</P>
<!-- /TABLE 2 -->
<HR>
<P>An interesting contrast in 
the effect of mutation on the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values for MgATP 
occurs between the two subunits. Whereas both the single and tandem 
mutations resulted in decreased <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values for MgATP 
on the dAK subunit, <i>i.e.</i>  whether or not the dAK subunit was 
altered, the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for MgATP on dGK was doubled for 
both mutants. No change was produced in the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for 
MgATP on dAK upon the binding of dGuo to dGK of UMCE (data not shown).<P><P>
<H4>Effects of Arg-79 Mutations on Substrate 
Turnover</H4>The other striking effect of mutations at Arg-79 is 
seen upon comparison of true maximum velocities which are proportional 
to the turnover number (<a href = "#T2">Table&nbsp;2</a>). The turnover of dAK was <i>increased</i>  8-fold by the tandem R79K mutation and nearly 
30-fold above that of UMCE by the R79K:dGK mutation, respectively. 
Under <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  conditions these stimulatory affects 
cannot be explained in terms of any alteration of substrate binding at 
the dAK active site, whereas the relatively large changes in the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values of both substrates for the dGK signal 
significant conformational changes at the dGK active site which may be 
capable of altering the ``tautness''  of the dAK subunit, like 
the positive heterotropic effector dGuo, but greater in magnitude. This 
is believed to be analogous to the somewhat smaller stimulatory effects 
on dAK activity which were detected following chemical modifications of 
the dGK active site(<a href = "#B8">8</a>) . The accompanying loss of stimulation 
by dGuo is certainly consistent with the notion that the dAK subunit 
was already locked into a much more active conformation by the mutation 
on the dGK subunit.<P>The other conclusion which can be inferred from 
these data is that, in terms of the <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">/<i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  ``efficiency 
ratios,''  the R29K mutations can be said to have had opposite 
effects on the activities of the two subunits. Whereas the efficiency 
of dAdo binding and turnover combined increased from 3- to 29-fold, 
that of dGuo was decreased 90%  or more. Since limiting values, <i>i.e.</i>  real <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  values and <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values, make up these ratios, it is even more apparent that 
asymmetry exists between the two subunits, despite their identical 
sequences within the motif which was mutagenized.<P><P>
<H4>Confirmation of Kinetic Mechanisms</H4>One other 
possibility remains to be examined: whether or not these mutations 
alter the kinetic mechanism of either subunit, which are known to 
differ in the wild-type dGK/dAK(<a href = "#B5">5</a>) . For example, might the 
ordered kinetic path followed by wild-type dAK be shifted to a random 
mechanism, <i>e.g.</i>  possibly allowing for a faster off-rate? This 
does not appear to be the case, judging from the following 
observations. The first, possibly trivial, observation is that the 
mutations produced no qualitative changes in the steady-state kinetics 
patterns. For example, with the dAK of UMCE, plots of 1/<i>V versus</i>  1/MgATP at various fixed concentrations of dAdo, or of 1/<i>V 
versus</i>  1/[dAdo]  at various fixed concentrations of 
MgATP, gave a family of straight-line plots converging at one point on 
the horizontal axis (results not shown). However, for the dGK component 
of UMCE, the plots of 1/<i>V versus</i>  the reciprocal concentration 
of MgATP or dGuo, at various fixed concentrations of the other 
substrate, gave a family of straight lines intersecting in the upper 
left-hand quadrant. The Arg-79 replacement mutants yielded patterns 
qualitatively identical to those just described. Neither pattern, by 
itself, defines whether the sequential kinetics is ordered or random, 
of course, but the absence of any mutationally induced shift in the 
point of intersection of either pattern of lines, at least suggests 
that the mechanism is unchanged.<P>Far more compelling evidence for 
unchanged kinetic mechanisms is provided by end product inhibition 
studies. Earlier work from this laboratory has established that with 
these enzymes, as well as with the dCyd kinase/dAdo kinase pair from <i>L. acidophilus</i>  R26, the respective dNTP end products mimic the 
effects of multisubstrate analogs(<a href = "#B5">5</a>) . Thus, in the case of 
random substrate binding, the multisubstrate analog or the homologous 
dNTP should compete with either substrate for the free enzyme, while 
for an ordered kinetic path these compounds will compete only with the 
leading substrate. For the wild-type dGK, dGTP competes with both dGuo 
and MgATP, consistent with a random mechanism, while for dAK dATP 
competes only with MgATP, the leading substrate in an ordered path, but 
is noncompetitive toward dAdo (<a href = "#B5">5</a>) . Identical conclusions as to 
differing kinetic mechanisms for the two activities were drawn earlier 
from classical product-inhibition analyses. However, the end product 
inhibition experiments used in the present work are practically simpler 
than the classical product-inhibition experiments used to establish the 
kinetic mechanisms of the wild-type enzymes, but provide clear-cut 
results. Dixon plots (1/<i>V versus</i>  [dNTP]  at several 
substrate concentrations) were used in obtaining numerical values for 
the inhibitor dissociation constants(<a href = "#B23">23</a>) . The <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_i.gif" ALT="(i)">  values for end product inhibition against each substrate were 
decreased up to 75%  in dAK, but were increased about 2-fold in dGK by 
both the R79K and R79K:dGK mutations (<a href = "#T3">Table&nbsp;3</a>). However, neither 
the dNTP inhibition pattern nor, therefore, the kinetic mechanism of 
either enzyme was affected by mutations at Arg-79; the kinetic path for 
dAK remains ordered, while that for dGK remains random. Therefore, 
mutation at Arg-79 affects only the substrate binding and turnover of 
the paired enzymes, not their kinetic mechanisms.<P><!-- TABLE 3 -->
<HR>
<P align=center>
<a name = "T3"><!-- comment for mosaic --></a>
<a HREF="/content/vol270/issue12/images/large/BC1257801003.jpeg">
<img SRC="/content/vol270/issue12/images/medium/BC1257801003.gif"></a>
</P>
<!-- /TABLE 3 -->
<HR>
<P><HR>
<P align=center>
<a name = "SEC3"><!-- comment for mosaic --></a>DISCUSSION<A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
</P>
<P>The heterodimeric deoxynucleoside kinases of <i>Lactobacillus</i>  present an array of important fundamental 
questions relating to the control of DNA precursor biosynthesis. These 
include the mechanism of end product inhibition of each activity, the 
structural basis of the exquisite deoxynucleoside specificity exhibited 
by each catalytic subunit and the positive heterotropic stimulation of 
dAdo turnover by dCyd or dGuo, respectively.<P>We elected to probe 
first the dGK/dAK DRS motifs, the conserved elements which by analogy 
with HSV TKs seemed likely to be associated with the deoxynucleoside 
sites. While we have no details yet of the dGK/dAK heterodimer's 
tertiary structure, a very preliminary prediction of the 
protein's secondary structure by the method of Chu and Fasman (<a href = "#B28">28</a>) or Garnier, <i>et al.</i>(<a href = "#B29">29</a>) suggests that the 
-DRS- motif may be at the turn of a loop. Therefore, if this local 
structure is involved in the binding of substrates or the stabilization 
of intermediates in the enzyme reaction, most substitutions should 
cause dramatic effects on enzyme activities. Accordingly, site-specific 
replacement of Asp-78 of both subunits with Glu, Asn, or Ala virtually 
abolished both the dGK and dAK activities of the mutants.<P>From the 
standpoint of uncovering the subtleties of enzyme regulation by subunit 
interaction, a much more interesting site of mutagenesis is found at 
Arg-79 of the <i>Lactobacillus</i>  enzyme upon charge-conservative 
replacements with Lys. Whereas the dGK activities of R79K and R79K:dGK 
were reduced substantially, the dAK activities of those mutant enzymes 
were elevated dramatically above that of UMCE. This phenomenon is 
thought to be analogous to the opposite-substrate activation effect 
reported previously with wild-type dCK/dAK and dGK/dAK (<a href = "#B6">6</a>, <a href = "#B7">7</a>) in which up to 6-fold stimulation of dAK 
activity occurs upon adding the opposite substrate, dCyd or dGuo, 
respectively, to the dAK reaction mixture. Arg-79-Lys mutations of the 
dGK subunit, either singly or in tandem with modification of the dAK 
subunit, essentially abolish this stimulation by dGuo, but, at the same 
time, produce an 8-28-fold increase in the <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  of dAK. Affinity-labeling of the dGK active site with 
8-azidoadenine produced a comparable, if smaller, effect(<a href = "#B8">8</a>) . 
We may presume that these modifications at or near what appears to be 
part of the dGK active site induce a conformational change in the dGK 
subunit similar to that produced by dGuo binding, and which, in turn, 
toggles the dAK subunit into its activated conformation. The smaller 
8-fold stimulation in the case of the tandem mutant is probably due to 
some offsetting reduction of efficiency of the dAK subunit upon its 
mutation. It is important to note, however, that for R79K:dGK the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for dAdo is unchanged, whereas it increases 
severalfold in the R79K mutant where both subunits are altered. 
Stimulation by dGuo has been shown to be purely a <i>V</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/sub_max.gif" ALT="(max)">  effect, producing no change in the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for 
dAdo(<a href = "#B7">7</a>) , and the R79K:dGK mutation seems to have had an 
identical effect. Recent work on the wild-type dGK/dAK in this 
laboratory suggests that selective modification of the dGK subunit by 
photoaffinity labeling may also lock dAK into its activated 
configuration(<a href = "#B8">8</a>) , an effect which is mediated therefore 
through the dGK subunit.<P>The R79K mutation has opposite effects on 
the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values for MgATP at the two active sites, 
but lower <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  values on dAK would not account for 
the stimulation as the assay is carried out under near-saturating 
conditions with respect to MgATP. Since these mutations are not within 
either of the putative ATP-binding domains of the protein, we 
tentatively assume that global folding or interactions between domains 
are affected. On dGK the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for MgATP is already 
much larger than on dAK, and is doubled again by the Arg-79 mutation. 
It should be noted that, even for the wild-type enzyme, the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for MgATP on the dGK subunit (1.7 mM) 
is an order larger than on dAK (0.11 mM). Although the 
conserved ATP-binding sites at the N termini are genetically identical, 
they do not appear to be processed alike after translation in either <i>Lactobacillus</i>  or the <i>E. coli</i>  host(<a href = "#B24">24</a>) . <P>The evidence pointing to asymmetry between the tertiary and/or 
quaternary structures of the two subunits can be summarized as follows. 
(i) We note that they follow different kinetic pathways, one ordered 
and one random, and the activation of dAK by dGuo or by the R79K:dGK 
mutation does not alter this. However, the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_i.gif" ALT="(i)">  for 
dATP is decreased by about the same extent as the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for MgATP, the leading substrate in the ordered mechanism. This 
is consistent with the understanding that dATP behaves as a 
multisubstrate analog bridging the deoxynucleoside and ATP-phosphate 
sites. (ii) The one-way stimulation of the dAK activity by dGuo or 
dGTP, by affinity labeling of the dGK subunit (<a href = "#B8">8</a>) and by R79K 
mutagenesis also supports this notion. (iii) The opposite effects of 
R79K replacement on the binding of MgATP to the two subunits, despite 
similar sequences, also suggests differences in folding or contact 
points of the heterodimer. For example, the subunits could be arranged 
in a head-to-tail fashion, effectively burying one of the N termini. <P>The detailed mechanism of the enhancement of dAK activity by R79K 
replacement is still unknown, but it seems most likely that Arg-79 is 
located near the contact area, possibly in a loop, between the dAK and 
dGK subunit, and the amino acid residues involved in the substrate 
binding site of one subunit might effect on the overall rate-limiting 
reaction steps of the paired subunit. Since the <i>K</i><IMG BORDER=0 ALIGN=MIDDLE SRC="/icons/symbolgifs/chars/tiny_m.gif" ALT="(m)">  for dAdo is not changed by the mutation on dGK, turnover of dAK 
rather than substrate-binding is affected, and we may regard dGuo as a 
positive heterotropic effector of a rate-limiting step in dAK 
catalysis.<P>
</TXT>
<HR>
		<P align=center>
		<a name = "foo"></a>
		FOOTNOTES
		<A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
		</P>
		<DL><DT><a name="FN20"><a href="#RFN20">*</a></a><DD>This work was supported in part by 
National Institutes of Health Grants CA-47828 and GM49635. The costs of 
publication of this article were defrayed in part by the payment of 
page charges. This article must therefore by hereby marked 
``<i>advertisement</i>''  in accordance with 18 U.S.C. 
Section 1734 solely to indicate this fact.<P></DD><DT><a name="FN50"><a href="#RFN50">&#167;</a></a><DD>Present address: Dept. of Biochemistry, State 
University of New York at Buffalo, Buffalo, NY 14214.<P></DD><DT><a name="FN53"><a href="#RFN53">&#182;</a></a><DD>Present address: Dept. of Biochemistry, 
Molecular and Cellular Biology, Northwestern University, Evanston, IL 
60208-3520.<P></DD><DT><a name="FN52"><a href="#RFN52">**</a></a><DD>To whom correspondence should be 
addressed: Dept. of Biochemistry, The Ohio State University, 484 W. 
12th Ave., Columbus, OH 43210-1292. Tel.: 614-292-0485; Fax: 
614-292-6773.<P></DD><DT><a name="FN1"><a href="#RFN1">(<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_1.gif" ALT="^1">)</a></a><DD>The abbreviations used are: TK, 
thymidine kinase; dGK, deoxyguanosine kinase; dAK, deoxyadenosine 
kinase; dCK, deoxycytidine kinase; UMCE, unmodified cloned enzyme; HSV, 
herpes simplex virus.<P></DD><DT><a name="FN2"><a href="#RFN2">(<IMG BORDER=0 ALIGN=TOP SRC="/icons/symbolgifs/smallnumbers/tiny_2.gif" ALT="^2">)</a></a><DD>S. Ikeda, personal 
communication.<P></DD></DL><HR>
<P align=center>
<a name = "ref"><!-- comment for mosaic --></a>
REFERENCES <A HREF="#top"><IMG border=0 hspace=3 SRC="/icons/back.GIF"></A>
</P>
<OL>
<LI><a name="B1"><!-- comment for mosaic --></a>  Ives, D. H., and Wang, S.-M. (1978) <i>Methods Enzymol.</i> <b>51,</b> 337-345  
<!-- HIGHWIRE ID="270:12:6602:1" --><A HREF="/cgi/external_ref?access_num=211383&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=211383&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B2"><!-- comment for mosaic --></a>  Bohman, C., and Eriksson, S. (1988) <i>Biochemistry</i> <b>27,</b> 4258-4265  
<!-- HIGHWIRE ID="270:12:6602:2" --><A HREF="/cgi/external_ref?access_num=2844225&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2844225&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B3"><!-- comment for mosaic --></a>  Datta, N. S., Shewach, D. S., Hurley, M. C., Mitchell, B. S., and Fox, I. H. (1989)  <i>Biochemistry</i> <b>28,</b> 114-123  
<!-- HIGHWIRE ID="270:12:6602:3" --><A HREF="/cgi/external_ref?access_num=2539852&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2539852&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B4"><!-- comment for mosaic --></a>  Ikeda, S., Ma, G. T., and Ives, D. H. (1994) <i>Biochemistry</i> <b>33,</b> 5328-5334  
<!-- HIGHWIRE ID="270:12:6602:4" --><A HREF="/cgi/external_ref?access_num=8172906&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8172906&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B5"><!-- comment for mosaic --></a>  Ikeda, S., Chakravarty, R., and Ives, D. H. (1986) <i>J. Biol. Chem. </i> <b>261,</b> 15836-15843  
<!-- HIGHWIRE ID="270:12:6602:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=261/34/15836"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->

<LI><a name="B6"><!-- comment for mosaic --></a>  Deibel, M. R., Jr., Reznik, R. B., and Ives, D. H. (1977) <i>J. Biol. Chem. </i> <b>252,</b> 8240-8244  
<!-- HIGHWIRE ID="270:12:6602:6" --><A HREF="/cgi/external_ref?access_num=199606&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=199606&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B7"><!-- comment for mosaic --></a>  Chakravarty, R., Ikeda, S., and Ives, D. H. (1984) <i>Biochemistry</i> <b>23,</b> 6235-6240  
<!-- HIGHWIRE ID="270:12:6602:7" --><A HREF="/cgi/external_ref?access_num=6098313&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6098313&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B8"><!-- comment for mosaic --></a>  Ikeda, S., and Ives, D. H. (1994) <i>Biochemistry</i> <b>33,</b> 13373-13381  
<!-- HIGHWIRE ID="270:12:6602:8" --><A HREF="/cgi/external_ref?access_num=7947746&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7947746&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B9"><!-- comment for mosaic --></a>  Ikeda, S., Swenson, R. P., and Ives, D. H. (1988) <i>Biochemistry</i> <b>27,</b> 8648-8652  
<!-- HIGHWIRE ID="270:12:6602:9" --><A HREF="/cgi/external_ref?access_num=2851331&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2851331&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B10"><!-- comment for mosaic --></a>  Fry, D. C., Kuby, S. A., and Mildvan, A. S. (1986) <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>83,</b> 907-911  
<!-- HIGHWIRE ID="270:12:6602:10" --><A HREF="/cgi/external_ref?access_num=2869483&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2869483&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B11"><!-- comment for mosaic --></a>  Tsai, M.-D., and Yan, H.  (1991) <i>Biochemistry</i> <b>30,</b> 6806-6818  
<!-- HIGHWIRE ID="270:12:6602:11" --><A HREF="/cgi/external_ref?access_num=2069947&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2069947&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B12"><!-- comment for mosaic --></a>  Balasubramaniam, N. K., Veerisetty, V., and Gentry, G. A. (1990) <i>J. Gen. Virol.</i> <b>71,</b> 2979-2987  
<!-- HIGHWIRE ID="270:12:6602:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=vir&resid=71/12/2979">[Abstract]</A><!-- /HIGHWIRE -->

<LI><a name="B13"><!-- comment for mosaic --></a>  Gentry, G. A.  (1992) <i>Pharmacol. Ther.</i> <b>54,</b> 319-355  
<!-- HIGHWIRE ID="270:12:6602:13" --><A HREF="/cgi/external_ref?access_num=1334563&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1334563&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B14"><!-- comment for mosaic --></a>  Darby, G., Larder, B. A., and Inglis, M. M. (1986) <i>J. Gen. Virol. </i> <b>67,</b> 753-758  
<!-- HIGHWIRE ID="270:12:6602:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=vir&resid=67/4/753">[Abstract]</A><!-- /HIGHWIRE -->

<LI><a name="B15"><!-- comment for mosaic --></a>  Munir, K. M., French, D. C., Dube, D. K., and Loeb, L. A. (1994) <i>Protein Eng. </i> <b>7,</b> 83-89  
<!-- HIGHWIRE ID="270:12:6602:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=proeng&resid=7/1/83">[Abstract]</A><!-- /HIGHWIRE -->

<LI><a name="B16"><!-- comment for mosaic --></a>  Suzutani, T., Davies, L. C., and Honess, R. W. (1993) <i>J. Gen. Virol. </i> <b>74,</b> 1011-1016  
<!-- HIGHWIRE ID="270:12:6602:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=vir&resid=74/6/1011">[Abstract]</A><!-- /HIGHWIRE -->

<LI><a name="B17"><!-- comment for mosaic --></a>  Black, M. E., and Loeb, L. A. (1993) <i>Biochemistry</i> <b>32,</b> 11618-11626  
<!-- HIGHWIRE ID="270:12:6602:17" --><A HREF="/cgi/external_ref?access_num=8218229&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8218229&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B18"><!-- comment for mosaic --></a>  Ives, D. H. (1984)  <i>Anal. Biochem.</i> <b>136,</b> 416-420  
<!-- HIGHWIRE ID="270:12:6602:18" --><A HREF="/cgi/external_ref?access_num=6326621&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6326621&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B19"><!-- comment for mosaic --></a>  Cretton, E. M., Xie, M.-Y., Goudgaon, N. M., Schinazi, R. F., Chu, C. K., and Sommadossi, J.-P. (1992) <i>Biochem. Pharmacol.</i> <b>44,</b> 973-980  
<!-- HIGHWIRE ID="270:12:6602:19" --><A HREF="/cgi/external_ref?access_num=1326966&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1326966&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B20"><!-- comment for mosaic --></a>  Laemmli, U. K.  (1970) <i>Nature</i> <b>227,</b> 680-685  
<!-- HIGHWIRE ID="270:12:6602:20" --><A HREF="/cgi/external_ref?access_num=5432063&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=5432063&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B21"><!-- comment for mosaic --></a>  Deibel, M. R., Jr., and Ives, D. H. (1978) <i>Methods Enzymol.</i> <b>51,</b> 346-354  
<!-- HIGHWIRE ID="270:12:6602:21" --><A HREF="/cgi/external_ref?access_num=211384&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=211384&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B22"><!-- comment for mosaic --></a>  Sanger, F., Nicklen, S., and Coulson, A. R. (1977) <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>74,</b> 5463-5467
<!-- HIGHWIRE ID="270:12:6602:22" --><A HREF="/cgi/external_ref?access_num=271968&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=271968&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B23"><!-- comment for mosaic --></a> Segel, I. H. (1975)  <i>Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems</i> , pp. 273-329, John Wiley &amp;  Sons, New York
<!-- HIGHWIRE ID="270:12:6602:23" --><!-- /HIGHWIRE --><LI><a name="B24"><!-- comment for mosaic --></a>  Ma, G. T., Hong, Y. S., and Ives, D. H. (1994) <i>J. Biol. Chem.</i> <b>270,</b> 6595-6601  
<!-- HIGHWIRE ID="270:12:6602:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/12/6595"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->

<LI><a name="B25"><!-- comment for mosaic --></a>  Chottiner, E. G., Shewach, D. S., Datta, N. S., Ashcraft, E., Gribbin, D., Ginsburg, D., Fox, I. H., and Mitchell, B. S. (1991) <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>88,</b> 1531-1535  
<!-- HIGHWIRE ID="270:12:6602:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=88/4/1531">[Abstract]</A><!-- /HIGHWIRE -->

<LI><a name="B26"><!-- comment for mosaic --></a>  Gao, W.-Y., Jaroszewski, J. W., Cohen, J. S., and Cheng, Y.-C. (1990) <i>J. Biol. Chem.</i> <b>265,</b> 20172-20178  
<!-- HIGHWIRE ID="270:12:6602:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/33/20172"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->

<LI><a name="B27"><!-- comment for mosaic --></a>  Kunkel, T. A.  (1985) <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>82,</b> 488-492  
<!-- HIGHWIRE ID="270:12:6602:27" --><A HREF="/cgi/external_ref?access_num=3881765&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3881765&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B28"><!-- comment for mosaic --></a>  Chou, P. Y., and Fasman, G. D. (1978) <i>Annu. Rev. Biochem.</i> <b>47,</b> 251-276  
<!-- HIGHWIRE ID="270:12:6602:28" --><A HREF="/cgi/external_ref?access_num=354496&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=354496&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->

<LI><a name="B29"><!-- comment for mosaic --></a>  Garnier, J., Osguthorpe, D. J., and Robson, B. (1978) <i>J. Mol. Biol. </i> <b>120,</b> 97-120  
<!-- HIGHWIRE ID="270:12:6602:29" --><A HREF="/cgi/external_ref?access_num=642007&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=642007&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
</OL><HR>
	&#169;1995 by The American Society for Biochemistry and Molecular Biology, Inc.
	<BR><BR> <HR>
</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.pnas.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.pnas.org"><IMG ALT="Proc. Natl. Acad. Sci. U. S. A." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	N. Ma, S. Ikeda, S. Guo, A. Fieno, I. Park, S. Grimme, T. Ikeda, and D.H. Ives<BR>
	<STRONG>Deoxycytidine kinase and deoxyguanosine kinase of Lactobacillus acidophilus R-26 are colinear products of a singlegene</STRONG><BR>
	
		
			PNAS,
		
	
        
        December&nbsp;10,&nbsp;1996;
	93(25):
	14385 - 14390.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/93/25/14385">[Abstract]</A>

<A HREF="http://www.pnas.org/cgi/content/full/93/25/14385">[Full Text]</A>
<A HREF="http://www.pnas.org/cgi/reprint/93/25/14385">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Guo and D. H. Ives<BR>
	<STRONG>Functional Assignment by Chimera Construction of the Domain Affecting Heterotropic Activation of Deoxyadenosine Kinase from Lactobacillus acidophilus R-26</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;9,&nbsp;1998;
	273(41):
	26624 - 26630.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/273/41/26624">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/273/41/26624">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/273/41/26624">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. T. Ma, Y. S. Hong, and D. H. Ives<BR>
	<STRONG>Cloning and Expression of the Heterodimeric Deoxyguanosine Kinase/Deoxyadenosine Kinase of Lactobacillus acidophilus R-26</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;24,&nbsp;1995;
	270(12):
	6595 - 6601.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/270/12/6595">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/270/12/6595">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/270/12/6595">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/270/12/6602">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/270/12/6602">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;270/12/6602">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/270/12/6602&title=Directed+Mutagenesis+of+Deoxyguanosine+Site+at+Arginine+79+Up-regulates+Turnover+on+Deoxyadenosine+Kinase+Subunit+of+Heterodimeric+Enzyme+from+Lactobacillus+acidophilus+R26">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;270/12/6602&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=7896799&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=7896799&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Hong+YS&link_type=AUTHORSEARCH">Hong, Y. S.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Ives+DH&link_type=AUTHORSEARCH">Ives, D. H.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;270/12/6602&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F270%2F12%2F6602"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;270/12/6602">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol270/issue12/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 1995 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
